Military aviators, special operations forces, and causal malaria prophylaxis.
U.S. military aviators are currently restricted to the use of chloroquine or doxycycline for malaria prophylaxis. Ground forces are allowed the additional option of taking mefloquine. These medications are begun before deployment, must be taken for 4 weeks after leaving the malarious area, and primaquine must be added to the regimen the last 2 of those 4 weeks. Compliance with this regimen is often poor, especially in populations who travel abroad frequently for short periods of time. Causal malaria prophylaxis offers potential benefits of decreased length of postdeployment regimens and obviates the need for a second medication for terminal prophylaxis. Potential obstacles include adverse drug reactions, cost, and rapid development of resistance to new medications by Plasmodium species, which should be weighed against the risks to health and mission success in each deployment.
Chambers
James A
JA
Headquarters Air Force Special Operations Command, Office of the Command Surgeon, Hurlburt Field, FL 32544, USA.
D000634:Aminoquinolines / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use*; D053626:Atovaquone; D001359:Aviation; D002738:Chloroquine / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D015767:Mefloquine / Q000627:therapeutic use; D008889:Military Personnel; D009285:Naphthoquinones / Q000627:therapeutic use; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D014481:United States
D000634:Aminoquinolines; D000962:Antimalarials; D004338:Drug Combinations; D009285:Naphthoquinones; C109496:atovaquone, proguanil drug combination; C055852:tafenoquine; D002738:Chloroquine; D011319:Primaquine; D004318:Doxycycline; D002727:Proguanil; D015767:Mefloquine; D053626:Atovaquone